Patent directory · USPTO A61K / A61P
Patents matching “Medicenna Therapeutics Inc.”
9 pharma patents match "Medicenna Therapeutics Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "Medicenna Therapeutics Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12404497
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
granted -
US 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 12274735
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
granted -
US 11680090
Interleukin-2 fusion proteins and uses thereof
granted -
US 11542312
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 11352402
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 10781242
Interleukin-2 fusion proteins and uses thereof
granted -
US 10106592
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 10093708
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted